mifepristone has been researched along with Local Neoplasm Recurrence in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (42.86) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Abd Jamil, AH; Chung, I; Mat Adenan, NA; Omar, IS | 1 |
| Cai, Y; Conzen, SD; Goyal, A; Hall, BA; Kocherginsky, M; Skor, MN; Wonder, EL | 1 |
| Brady, WE; Hoffman, JS; Mannel, RS; Rocereto, TF; Rotmensch, J; Shahin, MS; Small, L | 1 |
| Heikinheimo, O; Koivisto-Korander, R; Leminen, A | 1 |
| Olson, JJ | 1 |
| Eisenhauer, EA; Fisher, B; Norris, B; Panasci, L; Perrault, D; Pritchard, KI; Vandenberg, T | 1 |
| de Keizer, RJ; Haak, HR; Hagenouw-Taal, JC; van Dulken, H; van Seters, AP; Vielvoye, GJ | 1 |
1 review(s) available for mifepristone and Local Neoplasm Recurrence
| Article | Year |
|---|---|
Laboratory evidence for the hormonal dependency of meningiomas.
Topics: Combined Modality Therapy; Female; Glucocorticoids; Gonadal Steroid Hormones; Humans; Male; Meningeal Neoplasms; Meningioma; Mifepristone; Neoplasm Proteins; Neoplasm Recurrence, Local; Neoplasms, Hormone-Dependent; Receptors, Steroid; Sex Factors; Steroids | 1994 |
2 trial(s) available for mifepristone and Local Neoplasm Recurrence
| Article | Year |
|---|---|
A phase II evaluation of mifepristone in the treatment of recurrent or persistent epithelial ovarian, fallopian or primary peritoneal cancer: a gynecologic oncology group study.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Disease-Free Survival; Fallopian Tube Neoplasms; Female; Humans; Kaplan-Meier Estimate; Middle Aged; Mifepristone; Neoplasm Recurrence, Local; Ovarian Neoplasms; Peritoneal Neoplasms | 2010 |
Phase II study of the progesterone antagonist mifepristone in patients with untreated metastatic breast carcinoma: a National Cancer Institute of Canada Clinical Trials Group study.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Breast Neoplasms; Female; Hormone Antagonists; Humans; Liver Neoplasms; Middle Aged; Mifepristone; Neoplasm Recurrence, Local | 1996 |
4 other study(ies) available for mifepristone and Local Neoplasm Recurrence
| Article | Year |
|---|---|
MPA alters metabolic phenotype of endometrial cancer-associated fibroblasts from obese women via IRS2 signaling.
Topics: Acetates; Cancer-Associated Fibroblasts; Endometrial Neoplasms; Female; Glucose; Humans; Insulin Receptor Substrate Proteins; Medroxyprogesterone Acetate; Mifepristone; Neoplasm Recurrence, Local; Obesity; Phenotype; Progesterone; Receptors, Progesterone; RNA, Messenger | 2022 |
Glucocorticoid receptor antagonism as a novel therapy for triple-negative breast cancer.
Topics: Animals; Anti-Inflammatory Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Caspase 3; Cell Line, Tumor; Dexamethasone; Drug Resistance, Neoplasm; Dual Specificity Phosphatase 1; Female; Gene Expression; Hormone Antagonists; Humans; Immediate-Early Proteins; Mice; Mice, SCID; Mifepristone; Neoplasm Recurrence, Local; Neoplasm Transplantation; Paclitaxel; Poly(ADP-ribose) Polymerases; Protein Serine-Threonine Kinases; Receptors, Estrogen; Receptors, Glucocorticoid; Signal Transduction; Transplantation, Heterologous; Triple Negative Breast Neoplasms | 2013 |
Mifepristone as treatment of recurrent progesterone receptor-positive uterine leiomyosarcoma.
Topics: Diagnosis, Differential; Female; Hormone Antagonists; Humans; Leiomyosarcoma; Middle Aged; Mifepristone; Neoplasm Recurrence, Local; Neoplasm Staging; Radiography; Receptors, Progesterone; Uterine Neoplasms | 2007 |
Successful mifepristone treatment of recurrent, inoperable meningioma.
Topics: Drug Administration Schedule; Drug Evaluation; Female; Humans; Meningeal Neoplasms; Meningioma; Mifepristone; Neoplasm Recurrence, Local | 1990 |